Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Olmutinib | 1353550-13-6 | 99.5% / 99.9% | 486.59 | 200 MG
SDP

Catalog No. 5000400941
Encompass_Preferred

Olmutinib is an orally active and irreversible third-generation EGFR tyrosine kinase inhibitor. It binds to a cysteine residue near the kinase domain and is used for Non-Small Cell Lung Cancer (NSCLC). This product is for research use only.

  • Orally active
  • Irreversible third-generation EGFR tyrosine kinase inhibitor
  • Binds to a cysteine residue near the kinase domain
  • Used for Non-Small Cell Lung Cancer (NSCLC)
  • For research use only

Catalog No. 50-004-00941 Supplier Medchemexpress LLC Supplier No. HY19730200MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Olmutinib is an orally active and irreversible third-generation EGFR tyrosine kinase inhibitor. It binds to a cysteine residue near the kinase domain and is used for Non-Small Cell Lung Cancer (NSCLC). This product is for research use only.

  • Orally active
  • Irreversible third-generation EGFR tyrosine kinase inhibitor
  • Binds to a cysteine residue near the kinase domain
  • Used for Non-Small Cell Lung Cancer (NSCLC)
  • For research use only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.